Patent AnalyticsExaminers
Rankings

Company or institution

Amicus Therapeutics, Inc.

197 applicationsfiled 2007 to 2026

Allowance rate
87%
+12 pts vs the USPTO range 81% to 92%
Rejections before allowance
1.3
−0.2 vs the USPTO
Months to first action
10.5 mo
−8.1 vs the USPTO
Needed an RCE
32%
+5 pts vs the USPTO

Timeline

Applications by filing year: drag across the years to study a period

Allowed in green, abandoned in red, pending in grey. The figures above and the charts that can be recomputed by filing year follow the span you pick.

Compared with the office

Against every applicant before the USPTO

Unlock the comparison with the officeFree with an account. No card needed.

Create a free account

Trend

Allowance by filing year

Unlock the trendIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Domains

Where the applications fall

CPC subclasses

A61K Medical preparations151 apps
C07D Heterocyclic compounds17 apps
C12N Microorganisms or enzymes9 apps
A61P Therapeutic activity of compounds4 apps
G16B Bioinformatics4 apps
H10B 3 apps

Art units

162953 apps
165628 apps
162519 apps
162713 apps
16538 apps
OPAP8 apps

Who represents them

Law firms and agents on their applications

Bars show the share of decided applications that were allowed.

Unlock the firms on their applicationsIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Rejection fingerprint

What gets rejected, by statute

Share of parsed office actions raising each ground; blue is the USPTO.

Unlock the rejection fingerprintIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

What works

Allowance by strategy used

Unlock what works for this filerIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in

Interviews

Does an interview help?

Unlock the interview figuresFree with an account. No card needed.

Create a free account

Applications

Every application in the record

ApplicationTitleFiledStatusRejectionsRCEsTo 1st action
19710987METHOD FOR SELECTION OF HIGH M6P RECOMBINANT PROTEINS2026-06-17Pending00n/a
19335590High Concentration Alpha-Glucosidase Compositions For The Treatment Of Pompe Disease2025-09-22Pending00n/a
19333835METHODS OF TREATING FABRY DISEASE IN PATIENTS HAVING RENAL IMPAIRMENT2025-09-19Pending00n/a
15946211Method and apparatus for adaptive signal processing2012-01-10Allowed1012.0 mo
15768338Composition and method for controlled release2015-02-11Abandoned4123.0 mo
15567175Distributed ledger transaction verification2018-03-12Allowed3020.0 mo
15897542Thermal management of battery assemblies2021-04-13Pending2117.0 mo
15790697Machine learning model for anomaly detection2012-05-14Allowed1014.0 mo
15705946Wireless power transfer coil arrangement2015-06-15Abandoned4125.0 mo
15396059Catalyst for selective hydrogenation2018-07-16Allowed3022.0 mo
Unlock all 197 applications, each with its full timelineIncluded in Pro, from $29 a month. Cancel any time.

See plans Sign in